25 Nov

Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation

The covid-19 vaccine innovator has been able to take quick action against suspected misappropriation of proprietary information, apparently because of its effective mechanisms for monitoring use of its trade secrets

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth